{"product_id":"tirz-60mg-vial-hd-labs","title":"Tirz 60mg Vial - HD LABS","description":"\u003cp\u003eTirz epatide is a peptide studied extensively for its activity across key metabolic and incretin pathways. It functions as a \u003cstrong\u003edual receptor agonist\u003c\/strong\u003e, acting on:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGLP-1 (glucagon-like peptide-1) receptors\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGIP (glucose-dependent insulinotropic polypeptide) receptors\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThrough this dual mechanism, tirz epatide has been investigated for its effects on insulin secretion, regulation of hepatic glucose production, delayed gastric emptying, and appetite-related signalling.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003chr\u003e\n\u003ch3\u003eClinical Trial Evidence (Phase 3)\u003c\/h3\u003e\n\u003cp\u003eTirz epatide has undergone extensive \u003cstrong\u003ePhase 3 clinical evaluation\u003c\/strong\u003e in large, controlled trials.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eIn Phase 3 studies conducted under controlled conditions, tirz epatide demonstrated \u003cstrong\u003esubstantial and sustained reductions in body weight\u003c\/strong\u003e, with participants achieving \u003cstrong\u003eaverage weight reductions of up to approximately 22–23% over 72 weeks\u003c\/strong\u003e, depending on dose and study protocol.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003ePhase 3 programmes also evaluated long-term safety, tolerability, and metabolic outcomes, forming the basis for subsequent regulatory approvals in certain jurisdictions.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eOutcomes observed in clinical trials are dependent on controlled protocols and \u003cstrong\u003edo not guarantee similar results outside of clinical settings\u003c\/strong\u003e.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch3\u003eHow Tirz epatide Compares\u003c\/h3\u003e\n\u003cp\u003eTirzepatide is often discussed alongside other incretin-based peptides:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSemaglutide\u003c\/strong\u003e functions as a \u003cstrong\u003eGLP-1 receptor agonist only\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eTirz epatide\u003c\/strong\u003e is a \u003cstrong\u003edual agonist\u003c\/strong\u003e, targeting both \u003cstrong\u003eGLP-1 and GIP receptors\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eThis dual activity differentiates tirz epatide from earlier single-pathway GLP-1 compounds\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003ch3\u003eImportant Information\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eSupplied in \u003cstrong\u003elyophilised peptide format\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eRequires reconstitution \u003cbr\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eConsultation with a \u003cstrong\u003elicensed healthcare provider\u003c\/strong\u003e is essential prior to any consideration of use\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eClinical trial results may not reflect individual or real-world outcomes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003ch3\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003cp\u003eThis product is supplied strictly on an \u003cstrong\u003einformed purchaser basis\u003c\/strong\u003e. By purchasing, you acknowledge that:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eYou have independently researched tirz epatide and its regulatory status\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eYou have consulted, or will consult, a qualified healthcare professional prior to any use\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eYou understand that clinical trial outcomes do not constitute guarantees of effect\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eThe seller provides \u003cstrong\u003eno medical advice, dosing guidance, or therapeutic claims\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eThe \u003cstrong\u003eonus of lawful, safe, and appropriate use rests entirely with the purchaser\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"LIFE.OS","offers":[{"title":"Default Title","offer_id":54417613127998,"sku":null,"price":2050.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0970\/9826\/8990\/files\/HDTIRZ60MG_1.png?v=1788887368","url":"https:\/\/life-os.co.za\/products\/tirz-60mg-vial-hd-labs","provider":"LIFE.OS","version":"1.0","type":"link"}